Maltin Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$528K Sell
440
-2
-0.5% -$2.04K 0.18% 89
2026
Q1
$407K Hold
442
0.16% 93
2025
Q4
$475K Buy
442
+2
+0.5% +$1.91K 0.19% 85
2025
Q3
$336K Hold
440
0.14% 97
2025
Q2
$343K Sell
440
-20
-4% -$15.5K 0.15% 93
2025
Q1
$380K Hold
460
0.18% 92
2024
Q4
$355K Hold
460
0.17% 95
2024
Q3
$407K Buy
460
+1
+0.2% +$899 0.2% 83
2024
Q2
$416K Hold
459
0.22% 82
2024
Q1
$357K Hold
459
0.2% 88
2023
Q4
$268K Hold
459
0.17% 94
2023
Q3
$247K Hold
459
0.17% 99
2023
Q2
$215K Buy
+459
New +$192K 0.15% 97
2023
Q1
Sell
-633
Closed -$232K 108
2022
Q4
$232K Buy
+633
New +$224K 0.17% 94

Other funds holding LLY

Maltin Wealth Management's LLY Position: Q2 2026 in Review

Maltin Wealth Management reduced its Eli Lilly (LLY) stake by 0.45% in Q2 2026, selling an estimated $2.04K and leaving 440 shares worth $528K. The position accounts for 0.18% of the portfolio, ranked #89.

Maltin Wealth Management first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. 1,583 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Maltin Wealth Management held 440 shares of Eli Lilly worth $528K as of Q2 2026.
  • Maltin Wealth Management sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.18% of Maltin Wealth Management's portfolio in Q2 2026, its #89 holding.
  • Maltin Wealth Management first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • 1,583 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Maltin Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.